Unknown

Dataset Information

0

Spectrum of Genetic Mutations in Korean Pediatric Acute Lymphoblastic Leukemia.


ABSTRACT: The wide application of next-generation sequencing (NGS) technologies has led to the discovery of multiple genetic alterations in pediatric acute lymphoblastic leukemia (ALL). In this work, we aimed to investigate the mutational spectrum in pediatric ALL. We employed a St. Mary's customized NGS panel comprising 67 leukemia-related genes. Samples were collected from 139 pediatric ALL patients. Eighty-five patients (61.2%) harbored at least one mutation. In B-cell ALL, the RAS pathway is the most involved pathway, and the three most frequently mutated genes were NRAS (22.4%), KRAS (19.6%), and PTPN11 (8.4%). NRAS and PTPN11 were significantly associated with a high hyperdiploidy karyotype (p = 0.018 and p < 0.001, respectively). In T-cell ALL, the three most frequently mutated genes were NOTCH1 (37.5%), FBXW7 (16.6%), and PTEN (6.2%). Several pairs of co-occurring mutations were found: NRAS with SETD, NRAS with PTPN11 in B-cell ALL (p = 0.024 and p = 0.020, respectively), and NOTCH1 with FBXW7 in T-cell ALL (p < 0.001). The most frequent newly emerged mutation in relapsed ALL was NT5C2. We procured comprehensive genetic information regarding Korean pediatric ALL using NGS technology. Our findings strengthen the current knowledge of recurrent somatic mutations in pediatric ALL.

SUBMITTER: Yoo JW 

PROVIDER: S-EPMC9658397 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Spectrum of Genetic Mutations in Korean Pediatric Acute Lymphoblastic Leukemia.

Yoo Jae Won JW   Ahn Ari A   Lee Jong-Mi JM   Jo Suejung S   Kim Seongkoo S   Lee Jae Wook JW   Cho Bin B   Kim Yonggoo Y   Kim Myungshin M   Chung Nack-Gyun NG  

Journal of clinical medicine 20221026 21


The wide application of next-generation sequencing (NGS) technologies has led to the discovery of multiple genetic alterations in pediatric acute lymphoblastic leukemia (ALL). In this work, we aimed to investigate the mutational spectrum in pediatric ALL. We employed a St. Mary’s customized NGS panel comprising 67 leukemia-related genes. Samples were collected from 139 pediatric ALL patients. Eighty-five patients (61.2%) harbored at least one mutation. In B-cell ALL, the RAS pathway is the most  ...[more]

Similar Datasets

| S-EPMC9898934 | biostudies-literature
| S-EPMC4262138 | biostudies-literature
| S-EPMC9207762 | biostudies-literature
| S-EPMC8699354 | biostudies-literature
| S-EPMC10576863 | biostudies-literature
| S-EPMC3349849 | biostudies-literature
| S-EPMC10756719 | biostudies-literature
| S-EPMC4030177 | biostudies-literature
| S-EPMC5243866 | biostudies-literature